Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

BACKGROUND: Tumor vasculature frequently fails to supply sufficient levels of oxygen to tumor tissue resulting in radioresistant hypoxic tumors. To improve therapeutic outcome radiotherapy (RT) may be combined with cytotoxic agents. METHODS: In this study we have investigated the combination of RT w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagtvet, Eirik, Røe, Kathrine, Olsen, Dag R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193805/
https://www.ncbi.nlm.nih.gov/pubmed/21981945
http://dx.doi.org/10.1186/1748-717X-6-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193805/
https://www.ncbi.nlm.nih.gov/pubmed/21981945
http://dx.doi.org/10.1186/1748-717X-6-135

Ejemplares similares